SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-297655
Filing Date
2018-10-11
Accepted
2018-10-11 16:18:36
Documents
15
Period of Report
2018-11-29
Effectiveness Date
2018-10-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A d610922ddef14a.htm DEF 14A 699176
2 GRAPHIC g610922001.jpg GRAPHIC 42419
3 GRAPHIC g610922002.jpg GRAPHIC 45203
4 GRAPHIC g610922003.jpg GRAPHIC 7303
5 GRAPHIC g610922004.jpg GRAPHIC 16246
6 GRAPHIC g610922005.jpg GRAPHIC 33045
7 GRAPHIC g610922dsp2a.jpg GRAPHIC 5423
8 GRAPHIC g610922g1010064728129.jpg GRAPHIC 677
9 GRAPHIC g610922g1010064728207.jpg GRAPHIC 782
10 GRAPHIC g610922g1010064728894.jpg GRAPHIC 734
11 GRAPHIC g610922g17z11.jpg GRAPHIC 977
12 GRAPHIC g610922g63u25.jpg GRAPHIC 4874
13 GRAPHIC g610922g69c02.jpg GRAPHIC 924
14 GRAPHIC g610922g83x45.jpg GRAPHIC 844
15 GRAPHIC g610922g91p42.jpg GRAPHIC 8302
  Complete submission text file 0001193125-18-297655.txt   933415
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-50484 | Film No.: 181118530
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1